COVID‐19 in heart transplant recipients: Outcomes according to vaccination status-Reference-Cited by-同舟云学术

COVID‐19 in heart transplant recipients: Outcomes according to vaccination status

Published:2022-03-12 Issue:2 Volume:24 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transplant Infectious Dis

Author:

Burgos Lucrecia María¹^ORCID,Baro Vila Rocio Consuelo¹,Cabral Miguel Hector¹,Buscio Maria¹,Vrancic Mariano²,Botto Fernando³,Diez Mirta¹

Affiliation:

1. Pulmonary Hypertension and Transplant Department Instituto Cardiovascular de Buenos Aires Buenos Aires Argentina

2. Cardiac Surgery Department Instituto Cardiovascular de Buenos Aires Buenos Aires Argentina

3. Clinical Research Department Instituto Cardiovascular de Buenos Aires Buenos Aires Argentina

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13817

Reference5 articles.

1. COVID‐19 in recent heart transplant recipients: Clinicopathologic features and early outcomes

2. Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019

3. SARS-CoV-2 Variants in Patients with Immunosuppression

4. WHO Coronavirus (COVID‐19) Dashboard: Situation by Region Country Territory & Area.https://covid19.who.int/table. Accessed 12/1/2022.

5. COVID‐19 – Situación de nuevas variantes SARS‐CoV‐2 en Argentina.https://www.argentina.gob.ar/salud/coronavirus‐COVID‐19/informacion‐epidemiologica/enero‐2022‐0. Accessed 27/1/2022.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV2 infections in heart transplant recipients: Vaccines still are our greatest weapon;IJC Heart & Vasculature;2024-04

2. Evolution of the impact of the COVID‐19 pandemic on heart transplant recipients: Decreasing risk, improving perspective;Transplant Infectious Disease;2024-02-20

3. Coronavirus disease 2019 outcomes in heart transplant recipients: A large Australian cohort;The Journal of Heart and Lung Transplantation;2024-02

4. Real‐world experience of tixagevimab‐cilgavimab pre‐exposure prophylaxis in orthotopic heart transplant recipients;Transplant Infectious Disease;2023-02-27